ANCC AGACNP-BC study materials
ANCC AGACNP-BC study resources

ANCC AGACNP-BC cheat sheet

ANCC AGACNP-BC · Keep the key ideas within reach.

Quick reference

Assessment and Diagnosis

  • Anion gap = Na+ − (Cl− + HCO3−); normal is about 8–12 mEq/L. An elevated gap with metabolic acidosis suggests ketones, lactate, uremia, toxins, or salicylate.

  • ABG stepwise: pH determines acidemia or alkalemia; PaCO2 determines the respiratory component; HCO3 determines the metabolic component. Winter's formula: expected PaCO2 = 1.5 × HCO3 + 8 ± 2.

  • CURB-65: confusion, urea >7 mmol/L (BUN >19 mg/dL), RR ≥30/min, SBP <90 or DBP ≤60 mm Hg, age ≥65. Score 0–1 supports outpatient care, ≥2 consider admission, ≥3 severe.

  • qSOFA: RR ≥22/min, altered mentation, SBP ≤100 mm Hg. Two or more criteria flag high risk for sepsis and prompt further evaluation.

  • Wells criteria for PE: clinical signs of DVT, PE most likely diagnosis, HR >100, immobilization or surgery, prior VTE, hemoptysis, malignancy. Low pretest probability plus negative PERC can avoid D-dimer.

  • HEART score: history, ECG, age, risk factors, troponin. Scores 0–3 are low risk, 4–6 moderate risk, and 7–10 high risk for major adverse cardiac events.

  • Type 2 diabetes diagnosis: A1c ≥6.5%, fasting glucose ≥126 mg/dL, 2-hour OGTT ≥200 mg/dL, or random glucose ≥200 mg/dL with symptoms. Prediabetes A1c is 5.7–6.4%.

  • Ottawa ankle rule: obtain imaging only if pain in the malleolar zone plus inability to bear weight four steps or bone tenderness at the posterior malleolus or navicular; it applies without intoxication or distracting injury.

  • Depression screening: PHQ-2 score ≥3 prompts PHQ-9; PHQ-9 ≥10 suggests moderate depression and warrants further assessment.

Quick reference

Clinical Management and Plan of Care

  • Septic shock: measure lactate, obtain cultures, give broad-spectrum antibiotics within 1 hour, give 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L, then start norepinephrine if MAP <65 mm Hg.

  • DKA: give isotonic fluid, start insulin infusion after K+ ≥3.3 mEq/L, add dextrose when glucose <200–250 mg/dL, and monitor K+ and anion gap. Bicarbonate only if pH <6.9.

  • Acute severe asthma: repeated SABA, ipratropium, systemic corticosteroids; add IV magnesium sulfate for severe refractory symptoms; consider NIV only in selected cases.

  • ACS: chew aspirin 162–325 mg, give P2Y12 inhibitor and anticoagulant per protocol, and obtain ECG within 10 minutes. Primary PCI is preferred if available within 120 minutes.

  • Heart failure with reduced EF: initiate ARNI or ACE inhibitor/ARB, beta blocker, MRA, and SGLT2 inhibitor unless contraindicated. Diuretics treat congestion, not routine euvolemia.

  • Hypertension: stage 1 is 130–139/80–89 mm Hg; goal <130/80 for most adults, individualized for older adults or frailty. Start two drugs if BP ≥160/100 or ≥20/10 above goal.

  • Ischemic stroke: IV thrombolysis within 4.5 hours for eligible patients; thrombectomy up to 24 hours for selected large-vessel occlusion; check glucose and CT before thrombolysis.

  • COPD exacerbation: short-acting bronchodilators, systemic corticosteroids 5–7 days, antibiotics if increased purulence plus dyspnea or volume; target SpO2 88–92% in those at risk of hypercapnia.

  • Cirrhotic ascites: sodium restriction, spironolactone plus furosemide, therapeutic paracentesis for tense ascites; avoid NSAIDs and ACE inhibitors/ARBs in decompensated cirrhosis.

Quick reference

Pharmacologic and Non-pharmacologic Interventions

  • Vancomycin: target AUC24/MIC 400–600 for serious MRSA; avoid relying on trough alone; monitor renal function and adjust for obesity and renal impairment.

  • Warfarin: INR 2–3 for most AF and VTE; mechanical mitral valve 2.5–3.5; bridge with parenteral anticoagulant when thrombotic risk is high.

  • DOACs: dose by indication, renal function, age, weight, and interacting drugs; avoid in mechanical valves and moderate-severe mitral stenosis.

  • Metformin: do not initiate if eGFR <45; stop if eGFR ≤30; hold before iodinated contrast when eGFR 30–60 or with AKI risk.

  • ACE inhibitors/ARBs: monitor K+ and creatinine; stop with angioedema, pregnancy, bilateral renal artery stenosis, or symptomatic hypotension. Cough is more common with ACE inhibitors.

  • Opioid safety: co-prescribe naloxone for high overdose risk; combine with nonopioid multimodal analgesia; reassess sedation, respiratory rate, and bowel function.

  • Systemic corticosteroids: taper after >2–3 weeks of supraphysiologic dosing; abrupt withdrawal risks adrenal crisis; monitor glucose, blood pressure, and infection.

  • Nonpharmacologic care: CBT and motivational interviewing for behavior change; physical therapy for mobility; sleep hygiene and CPAP for OSA; DASH diet and sodium restriction for hypertension.

Quick reference

Health Promotion, Patient Education, and Care Coordination

  • Colorectal cancer screening for average risk: start at 45 and continue to 75; colonoscopy every 10 years or annual FIT; earlier or interval screening for family history or symptoms.

  • Breast cancer screening: USPSTF recommends biennial mammography for ages 40–74; individualized shared decision-making for age 75 and older.

  • Cervical cancer screening: ages 21–29 cytology every 3 years; ages 30–65 cytology every 3 years, HPV testing every 5 years, or co-testing every 5 years.

  • Lung cancer screening: annual low-dose CT for ages 50–80 with ≥20 pack-year history who currently smoke or quit within 15 years.

  • Adult vaccines: annual influenza; Tdap every 10 years; zoster at age ≥50; pneumococcal at age ≥65 or with risk conditions; COVID-19 per current schedule.

  • Teach-back: ask the patient to restate the plan in their own words; this confirms understanding and identifies health literacy gaps.

  • Care transitions: medication reconciliation at admission, transfer, and discharge; written discharge plan; follow-up within 7 days for high-risk patients; clear warning signs.

  • SBAR: situation, background, assessment, recommendation; it standardizes handoffs and reduces communication errors.

Quick reference

Professional Role, Ethics, and Healthcare Delivery Systems

  • APRN practice scope and prescriptive authority derive from state nurse practice acts; some states require collaborative agreements, while others allow independent practice.

  • Informed consent requires capacity, disclosure of diagnosis, treatment, risks, benefits, alternatives, and voluntary choice; emergencies may allow treatment without consent.

  • HIPAA permits disclosure for treatment, payment, and operations; the minimum necessary standard applies; suspected abuse is reported as required by law.

  • EMTALA: Medicare-participating emergency departments must provide a medical screening examination and stabilizing treatment regardless of insurance or ability to pay.

  • Ethical principles: autonomy, beneficence, nonmaleficence, and justice; for incapacitated patients, apply surrogate decision-making by substituted judgment.

  • MIPS: quality, cost, improvement activities, and promoting interoperability; scores affect Medicare payment adjustments.

  • Mandatory reporting: suspected child or elder abuse, certain communicable diseases, and specified injuries per state law; report in good faith.

  • Impaired colleague: protect patients first, report through the appropriate chain, and use employee assistance or state diversion programs when indicated.